XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Total Parent Equity
Total Parent Equity
Cumulative Effect, Period of Adoption, Adjustment
Non-controlling Interests in Subsidiaries
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member                  
Beginning balance (in shares) at Dec. 31, 2019     145,378,158              
Beginning balance at Dec. 31, 2019 $ 3,695,500 $ (11,432) $ 145,378 $ 98,777 $ (1,141,308) $ 4,571,860 $ (11,432) $ 3,674,707 $ (11,432) $ 20,793
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 136,535         136,535   136,535    
Other comprehensive loss, net of tax (192,021)       (192,021)     (192,021)    
Cash dividends declared (114,476)         (114,476)   (114,476)    
Share-based awards exercised, including tax benefit (in shares)     7,629              
Share-based awards exercised, including tax benefit (341)   $ 7 (348)       (341)    
Share-based compensation 5,449     5,449       5,449    
Purchase of stock (in shares)     (1,136,444)              
Purchase of stock (95,719)   $ (1,136)     (94,583)   (95,719)    
Noncontrolling interest activities (464)                 (464)
Ending balance (in shares) at Mar. 31, 2020     144,249,343              
Ending balance at Mar. 31, 2020 3,423,031   $ 144,249 103,878 (1,333,329) 4,487,904   3,402,702   20,329
Beginning balance (in shares) at Dec. 31, 2020     144,354,335              
Beginning balance at Dec. 31, 2020 3,218,003 $ 6,223 $ 144,354 117,165 (1,036,502) 3,979,779 $ 6,223 3,204,796 $ 6,223 13,207
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 217,710         217,710   217,710    
Other comprehensive loss, net of tax 12,742       12,742     12,742    
Cash dividends declared (117,714)         (117,714)   (117,714)    
Share-based awards exercised, including tax benefit (in shares)     103,722              
Share-based awards exercised, including tax benefit (5,429)   $ 104 (5,533)       (5,429)    
Share-based compensation 6,235     6,235       6,235    
Noncontrolling interest activities (1,661)                 (1,661)
Ending balance (in shares) at Mar. 31, 2021     144,458,057              
Ending balance at Mar. 31, 2021 $ 3,336,109   $ 144,458 $ 117,867 $ (1,023,760) $ 4,085,998   $ 3,324,563   $ 11,546